Author:
Morbelli Silvia,Calcagni Maria Lucia,Cistaro Angelina,Farsad Mohsen,Guerra Luca,Nanni Cristina,Bianchi Andrea
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging
Reference49 articles.
1. Bietendorf J (2004) FDG PET Reimbursement. J. Nucl Med Technol 32(1):33–38
2. Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT et al (2013) Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e211S–e250S
3. Ramnath N, Dilling TJ, Harris LJ, Kim AW, Michaud GC, Balekian AA et al (2013) Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143(5 Suppl):e314S–e340S
4. Rami-Porta R, Bolejack V, Giroux DJ, Chansky K, Crowley J, Asamura H et al (2014) International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members and Participating Institutions. The IASLC Lung Cancer Staging Project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 9:1618–1624
5. Detterbeck F (2016) Developing a prognostic prediction model for lung cancer. In: Rami-Porta R (ed) Staging manual in thoracic oncology, 2nd edn. Editorial Rx Press, North Fort Meyers, pp 237–258